A 58-year-old Caucasian female presents to your office for a recheck. She has had type 2 diabetes mellitus (T2DM) for 16 years and has a history of hypertension, dyslipidemia, and obesity, with minimal diabetic retinopathy and albuminuria. Despite active titration of her insulin, she continues to have consistent hyperglycemia.
Obstructive sleep apnea is a common and underdiagnosed condition in patients with type 2 diabetes. This blog post explores what is known about the underlying mechanism that may relate sleep apnea to diabetes.
Over the past six months we have had more questions than answers about the risk of incretin therapy (DPP-4 inhibitors and GLP-1 agonists) and the increased risks for both pancreatitis and pancreatic carcinoma.
With all the things I have to cover during my 20 minute follow-up visits with my patients with diabetes, I sometimes struggle with whether or not to interruptas they tell me about something that, at first, seems irrelevant, at least to me.
Dr. Jack Leahy, endocrinologist and general internist, Dr. Doron Schneider, weigh different initial treatment options presented by leading endocrinologists Silvio Inzucchi, MD, Alan J. Garber, MD and Laurence Kennedy, MD. (50:19)